An open-label, sequential, two-period drug-drug interaction (DDI) study, assessing effects of itraconazole on pharmacokinetics (PK) of ceralifimod (ONO-4641) in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 16 Dec 2015
At a glance
- Drugs Ceralifimod (Primary) ; Itraconazole
- Indications Multiple sclerosis
- Focus Pharmacokinetics
- 16 Dec 2015 New trial record